SlideShare a Scribd company logo
A seminar   on    Factor affecting IVIVC Guided by:   Presented by: Dr.Manish.P.Patel  Patel Jignesh.P  Head of Department  M.pharm-1sem Department of pharmaceutics  M.pharm, Nootan Pharmacy college Visnagar. 1/37
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],2/37
[object Object],[object Object],[object Object],[object Object],3/37
[object Object],[object Object],[object Object],[object Object],4/37
WHAT IS IVIVC??? ,[object Object],[object Object],[object Object],[object Object],5/37
WHY TO GO FOR IVIVC??? ,[object Object],[object Object],[object Object],[object Object],6/37
7/37 To explore the  relationship  To assist  quality  control  for certain  SUPAC. Research tool for Formulation  Screening To support  biowaivers  for  bioequivalence  testing  Development of  drug delivery  systems. To set the  dissolution  specifications As a surrogate of  in vivo bioavailability  To reduce  the number of human studies   IMPORTANCE  OF IVIVC
Establishing in vitro-in vivo correlation  ,[object Object],[object Object],[object Object],8/37
Factors affecting development  of a predictable IVIVC 9/37 DISSOLUTION  METHOD PYSICOCHEMICAL METHOD COMPOSITION COMPLEXITY
Mean Residence Time: MRT = AUMC / AUC where, AUMC = Area under first moment Curve  (Concentration*time Vs time) AUC = Area under zero moment curve  (Concentration Vs time) Mean Absorption Time: MAT = MRT  oral  – MRT  i.v. Mean In-vivo Dissolution Time:   MDT  solid  = MRT  solid  – MRT  solution Percent Prediction Error:   % PE = [(Observed value – Predicted value) / Observed value] x 100 FEW DEFINITIONS 10/37
LEVELS OF CORRELATION ,[object Object],11/37 Level A Level B Level C Multiple C
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],LEVEL A CORRELATION 12/37
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Level B Correlation 13/37
[object Object],[object Object],[object Object],[object Object],Level C Correlation  14/37
[object Object],[object Object],[object Object],15/37 C max , T max , K a , Time to have 10, 50, 90% absorbed, AUC Disintegration time, Time to have 10, 50, 90% Dissolved, Dissolution rate, Dissolution efficiency C Statistical Moment: MRT,  MAT Statistical Moment: MDT B Input (absorption) curves Dissolution curve  A In vivo In vitro Level
Types of correlation ,[object Object],[object Object],[object Object],[object Object],16/37 No Linear Relationship 0 Perfect  Negative -1 Perfect  Positive +1 Linear relationship Correlation (r) between variables
17/37 Correlation  Methods SIMPLE  POINT  TYPE COMPARISON  OF  PROFILES   DIRECT  DIFFERENTIAL  EQUATION- BASED  IVIVC
18/37 ,[object Object],[object Object],3. Percent drug absorbed time profile ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],In vivo data ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],In vitro data
STAGES OF IVIVC MODEL  MODEL DEVELOPMENT 19/37 MODEL VALIDATION
Model Development ,[object Object],[object Object],[object Object],[object Object],20/37
21/37 Limited or no IVIVC expected.  Low Low IV Absorption/Permeability is rate determining and limited or no correlation with dissolution rate. Low High III IVIVC is expected  if in-vitro dissolution rate is similar to in-vivo dissolution rate, unless dose is very high.  High Low II IVIVC: if dissolution rate is slower than gastric emptying rate. Otherwise limited or no correlation required  High High I IVIVC EXPECTATION  PERMEABILITY  SOLUBILITY  CLASS
[object Object],[object Object],[object Object],[object Object],22/37
[object Object],[object Object],[object Object],[object Object],23/37
Determining the fraction of dose absorbed ,[object Object],[object Object],[object Object],[object Object],[object Object],24/37
Model Validation  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],25/37
Internal Validation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],26/37
External Validation ,[object Object],[object Object],[object Object],27/37
28/37 IVIVC – PARENTERAL  DRUG DELIVERY DISSOLUTION  SPECIFICATIONS FORMULATION  ASSESSMENT EARLY STAGES  OF DRUG DELIVERY  TECHNOLOGY  DEVELOPMENT FUTURE  BIOWAIVERS APPLICATIONS  OF IVIVC  IN DRUG DELIVERY  Potent Drugs & Chronic Therapy  Limited volume  Burst Release
CAUSES OF FAILURE OF PARENTERAL IVIVC ,[object Object],[object Object],[object Object],[object Object],29/37
WHATS IN STORE FOR THE FUTURE>>> ,[object Object],[object Object],[object Object],[object Object],[object Object],30/37
DISSOLUTION SIMULATORS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],31/37
GRONINGS MODEL GLASS BEADS SINTERED GLASS FILTER AXIS OF ROTATION SINTERED GLASS FILTER POROUS PLASTIC ,[object Object],[object Object],[object Object],32/37
CONCLUSION ,[object Object],[object Object],[object Object],[object Object],33/37
STUDY QUESTIONS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],34/37
REFERENCES ,[object Object],[object Object],[object Object],35/37
[object Object],[object Object],[object Object],[object Object],36/37
“ THERE IS ALWAYS SOMETHING MORE THAN YOU CAN DO” 37/37

More Related Content

What's hot

IVIVC-
IVIVC-IVIVC-
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis
Naveen Reddy
 
OPTIMIZATION IN PHARMACEUTICS,FORMULATION & PROCESSING
OPTIMIZATION IN PHARMACEUTICS,FORMULATION & PROCESSINGOPTIMIZATION IN PHARMACEUTICS,FORMULATION & PROCESSING
OPTIMIZATION IN PHARMACEUTICS,FORMULATION & PROCESSING
Jamia Hamdard
 
bioavailability & bioequivalence
bioavailability & bioequivalence bioavailability & bioequivalence
bioavailability & bioequivalence
BINDIYA PATEL
 
Biological and physicochemical factors affecting bioavailability
Biological and physicochemical factors affecting bioavailabilityBiological and physicochemical factors affecting bioavailability
Biological and physicochemical factors affecting bioavailability
Aly Nada
 
Regulatory aspects of bioequivalence iss xr4-revised
Regulatory aspects of bioequivalence iss xr4-revisedRegulatory aspects of bioequivalence iss xr4-revised
Regulatory aspects of bioequivalence iss xr4-revised
E. Dennis Bashaw
 
In vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, Punjab
In vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, PunjabIn vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, Punjab
In vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, Punjab
Neeraj Mishra
 
Bioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence pptBioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence ppt
Aditya Sharma
 
Preformation supriya
Preformation supriyaPreformation supriya
Preformation supriya
Supriya hiremath
 
Ethics of computing in pharmaceutical research
Ethics of computing in pharmaceutical researchEthics of computing in pharmaceutical research
Ethics of computing in pharmaceutical research
SUJITHA MARY
 
Dissolution models (sem 1)
Dissolution models (sem 1)Dissolution models (sem 1)
Dissolution models (sem 1)
HARSHALA DHENDE
 
kinetics of drug interactions
kinetics of drug interactionskinetics of drug interactions
kinetics of drug interactions
1918225
 
Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing
Amit Attri
 
cosmetics - regulatory : Regulatory provisions related to cosmetics
cosmetics - regulatory : Regulatory provisions related to cosmetics cosmetics - regulatory : Regulatory provisions related to cosmetics
cosmetics - regulatory : Regulatory provisions related to cosmetics
PV. Viji
 
Validation of pharmaceutical industries
Validation of pharmaceutical industriesValidation of pharmaceutical industries
Validation of pharmaceutical industries
Prima Ramadhani
 
bioequivalence study design
bioequivalence study designbioequivalence study design
bioequivalence study design
Juhi Priya
 
Kinetics of stability studies
Kinetics of stability studiesKinetics of stability studies
Kinetics of stability studies
ROHIT
 
In vivo in vitro correlation - copy
In vivo in vitro correlation - copyIn vivo in vitro correlation - copy
In vivo in vitro correlation - copy
BHUPINDER KAUR
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATION
N Anusha
 

What's hot (20)

IVIVC-
IVIVC-IVIVC-
IVIVC-
 
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis
 
OPTIMIZATION IN PHARMACEUTICS,FORMULATION & PROCESSING
OPTIMIZATION IN PHARMACEUTICS,FORMULATION & PROCESSINGOPTIMIZATION IN PHARMACEUTICS,FORMULATION & PROCESSING
OPTIMIZATION IN PHARMACEUTICS,FORMULATION & PROCESSING
 
bioavailability & bioequivalence
bioavailability & bioequivalence bioavailability & bioequivalence
bioavailability & bioequivalence
 
Biological and physicochemical factors affecting bioavailability
Biological and physicochemical factors affecting bioavailabilityBiological and physicochemical factors affecting bioavailability
Biological and physicochemical factors affecting bioavailability
 
Regulatory aspects of bioequivalence iss xr4-revised
Regulatory aspects of bioequivalence iss xr4-revisedRegulatory aspects of bioequivalence iss xr4-revised
Regulatory aspects of bioequivalence iss xr4-revised
 
In vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, Punjab
In vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, PunjabIn vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, Punjab
In vitro in vivo correlation by Dr. Neeraj Mishra, ISFCP, Moga, Punjab
 
Bioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence pptBioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence ppt
 
Preformation supriya
Preformation supriyaPreformation supriya
Preformation supriya
 
Ethics of computing in pharmaceutical research
Ethics of computing in pharmaceutical researchEthics of computing in pharmaceutical research
Ethics of computing in pharmaceutical research
 
Dissolution models (sem 1)
Dissolution models (sem 1)Dissolution models (sem 1)
Dissolution models (sem 1)
 
kinetics of drug interactions
kinetics of drug interactionskinetics of drug interactions
kinetics of drug interactions
 
Neethu ppt
Neethu pptNeethu ppt
Neethu ppt
 
Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing
 
cosmetics - regulatory : Regulatory provisions related to cosmetics
cosmetics - regulatory : Regulatory provisions related to cosmetics cosmetics - regulatory : Regulatory provisions related to cosmetics
cosmetics - regulatory : Regulatory provisions related to cosmetics
 
Validation of pharmaceutical industries
Validation of pharmaceutical industriesValidation of pharmaceutical industries
Validation of pharmaceutical industries
 
bioequivalence study design
bioequivalence study designbioequivalence study design
bioequivalence study design
 
Kinetics of stability studies
Kinetics of stability studiesKinetics of stability studies
Kinetics of stability studies
 
In vivo in vitro correlation - copy
In vivo in vitro correlation - copyIn vivo in vitro correlation - copy
In vivo in vitro correlation - copy
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATION
 

Similar to Jignesh patel,ivivc

Invitro invivo correlation
Invitro invivo correlationInvitro invivo correlation
Invitro invivo correlation
kvineetha8
 
In vitro In vivo correlation.pptx
In vitro In vivo correlation.pptxIn vitro In vivo correlation.pptx
In vitro In vivo correlation.pptx
SimonGermany1
 
Invitro invivo correlation
Invitro invivo correlationInvitro invivo correlation
Invitro invivo correlation
Nagaraju Ravouru
 
In Vitro In vivo Correlation
In Vitro In vivo CorrelationIn Vitro In vivo Correlation
In Vitro In vivo Correlation
Nilesh Kulkarni
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
AditiChauhan701637
 
Iv dissolution iviv corelation
Iv dissolution iviv corelationIv dissolution iviv corelation
Iv dissolution iviv corelation
Zahid1392
 
Ivivc
IvivcIvivc
IN VITRO IN VIVO CORRELATION
IN VITRO IN VIVO CORRELATION IN VITRO IN VIVO CORRELATION
IN VITRO IN VIVO CORRELATION
aldiwanyan teaching hospital
 
correlation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptxcorrelation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptx
GirijaSoori
 
In vitro-in-vivo-correlation-ivivc-a-strategic-tool-in-drug-development-jbb.s...
In vitro-in-vivo-correlation-ivivc-a-strategic-tool-in-drug-development-jbb.s...In vitro-in-vivo-correlation-ivivc-a-strategic-tool-in-drug-development-jbb.s...
In vitro-in-vivo-correlation-ivivc-a-strategic-tool-in-drug-development-jbb.s...
Md. Mizanur Rahman
 
In-Vitro-In Vivo (IVIVC).pdf
In-Vitro-In Vivo (IVIVC).pdfIn-Vitro-In Vivo (IVIVC).pdf
In-Vitro-In Vivo (IVIVC).pdf
Prachi Pandey
 
INVITRO-INVIBO CORELATION
INVITRO-INVIBO CORELATIONINVITRO-INVIBO CORELATION
INVITRO-INVIBO CORELATION
Syed Umar Farooq
 
Madhu k s
Madhu k s Madhu k s
Madhu k s
Madhu Honey
 
in vivo in vitro
in vivo in vitroin vivo in vitro
in vivo in vitro
Md. Mizanur Rahman
 
IVIV correlation.pptx
IVIV correlation.pptxIVIV correlation.pptx
IVIV correlation.pptx
Hariomjaiswal14
 
Invitro invivo correlation
Invitro invivo correlationInvitro invivo correlation
Invitro invivo correlation
PALLAB PAL
 
Iviv corelation
Iviv corelationIviv corelation
Iviv corelation
Zahid1392
 
In-Vivo In-Vitro Correlation
In-Vivo In-Vitro CorrelationIn-Vivo In-Vitro Correlation
In-Vivo In-Vitro Correlation
dilip kumar tampula
 
IVIVC detail topic explanation biopharmaceutics.pdf
IVIVC detail topic explanation biopharmaceutics.pdfIVIVC detail topic explanation biopharmaceutics.pdf
IVIVC detail topic explanation biopharmaceutics.pdf
UVAS
 

Similar to Jignesh patel,ivivc (20)

Invitro invivo correlation
Invitro invivo correlationInvitro invivo correlation
Invitro invivo correlation
 
In vitro In vivo correlation.pptx
In vitro In vivo correlation.pptxIn vitro In vivo correlation.pptx
In vitro In vivo correlation.pptx
 
Invitro invivo correlation
Invitro invivo correlationInvitro invivo correlation
Invitro invivo correlation
 
In Vitro In vivo Correlation
In Vitro In vivo CorrelationIn Vitro In vivo Correlation
In Vitro In vivo Correlation
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
Iv dissolution iviv corelation
Iv dissolution iviv corelationIv dissolution iviv corelation
Iv dissolution iviv corelation
 
Ivivc
IvivcIvivc
Ivivc
 
IN VITRO IN VIVO CORRELATION
IN VITRO IN VIVO CORRELATION IN VITRO IN VIVO CORRELATION
IN VITRO IN VIVO CORRELATION
 
correlation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptxcorrelation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptx
 
In vitro-in-vivo-correlation-ivivc-a-strategic-tool-in-drug-development-jbb.s...
In vitro-in-vivo-correlation-ivivc-a-strategic-tool-in-drug-development-jbb.s...In vitro-in-vivo-correlation-ivivc-a-strategic-tool-in-drug-development-jbb.s...
In vitro-in-vivo-correlation-ivivc-a-strategic-tool-in-drug-development-jbb.s...
 
In-Vitro-In Vivo (IVIVC).pdf
In-Vitro-In Vivo (IVIVC).pdfIn-Vitro-In Vivo (IVIVC).pdf
In-Vitro-In Vivo (IVIVC).pdf
 
INVITRO-INVIBO CORELATION
INVITRO-INVIBO CORELATIONINVITRO-INVIBO CORELATION
INVITRO-INVIBO CORELATION
 
Madhu k s
Madhu k s Madhu k s
Madhu k s
 
in vivo in vitro
in vivo in vitroin vivo in vitro
in vivo in vitro
 
IVIV correlation.pptx
IVIV correlation.pptxIVIV correlation.pptx
IVIV correlation.pptx
 
IVIVC
IVIVCIVIVC
IVIVC
 
Invitro invivo correlation
Invitro invivo correlationInvitro invivo correlation
Invitro invivo correlation
 
Iviv corelation
Iviv corelationIviv corelation
Iviv corelation
 
In-Vivo In-Vitro Correlation
In-Vivo In-Vitro CorrelationIn-Vivo In-Vitro Correlation
In-Vivo In-Vitro Correlation
 
IVIVC detail topic explanation biopharmaceutics.pdf
IVIVC detail topic explanation biopharmaceutics.pdfIVIVC detail topic explanation biopharmaceutics.pdf
IVIVC detail topic explanation biopharmaceutics.pdf
 

Recently uploaded

The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 

Recently uploaded (20)

The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 

Jignesh patel,ivivc

  • 1. A seminar on Factor affecting IVIVC Guided by: Presented by: Dr.Manish.P.Patel Patel Jignesh.P Head of Department M.pharm-1sem Department of pharmaceutics M.pharm, Nootan Pharmacy college Visnagar. 1/37
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7. 7/37 To explore the relationship To assist quality control for certain SUPAC. Research tool for Formulation Screening To support biowaivers for bioequivalence testing Development of drug delivery systems. To set the dissolution specifications As a surrogate of in vivo bioavailability To reduce the number of human studies IMPORTANCE OF IVIVC
  • 8.
  • 9. Factors affecting development of a predictable IVIVC 9/37 DISSOLUTION METHOD PYSICOCHEMICAL METHOD COMPOSITION COMPLEXITY
  • 10. Mean Residence Time: MRT = AUMC / AUC where, AUMC = Area under first moment Curve (Concentration*time Vs time) AUC = Area under zero moment curve (Concentration Vs time) Mean Absorption Time: MAT = MRT oral – MRT i.v. Mean In-vivo Dissolution Time: MDT solid = MRT solid – MRT solution Percent Prediction Error: % PE = [(Observed value – Predicted value) / Observed value] x 100 FEW DEFINITIONS 10/37
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17. 17/37 Correlation Methods SIMPLE POINT TYPE COMPARISON OF PROFILES DIRECT DIFFERENTIAL EQUATION- BASED IVIVC
  • 18.
  • 19. STAGES OF IVIVC MODEL MODEL DEVELOPMENT 19/37 MODEL VALIDATION
  • 20.
  • 21. 21/37 Limited or no IVIVC expected. Low Low IV Absorption/Permeability is rate determining and limited or no correlation with dissolution rate. Low High III IVIVC is expected if in-vitro dissolution rate is similar to in-vivo dissolution rate, unless dose is very high. High Low II IVIVC: if dissolution rate is slower than gastric emptying rate. Otherwise limited or no correlation required High High I IVIVC EXPECTATION PERMEABILITY SOLUBILITY CLASS
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28. 28/37 IVIVC – PARENTERAL DRUG DELIVERY DISSOLUTION SPECIFICATIONS FORMULATION ASSESSMENT EARLY STAGES OF DRUG DELIVERY TECHNOLOGY DEVELOPMENT FUTURE BIOWAIVERS APPLICATIONS OF IVIVC IN DRUG DELIVERY Potent Drugs & Chronic Therapy Limited volume Burst Release
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37. “ THERE IS ALWAYS SOMETHING MORE THAN YOU CAN DO” 37/37